Elevated Serum IL-17 Expression at Cessation Associated with Graves' Disease Relapse.

Conclusions: This present study indicated elevated serum IL-17 expression at cessation to be a predictor for GD relapse within 12 months. PMID: 29713343 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/29713343?dopt=Abstract

Source: International Journal of Endocrinology - May 3, 2018 Category: Endocrinology Tags: Int J Endocrinol Source Type: research

More News: Endocrinology | Study